# Pharmtechnology LLC clinical trials: 27 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 27 trials with Pharmtechnology LLC as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Pharmtechnology LLC: 27 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/pharmtechnology-llc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 27
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 27, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 19, 2024 | NCT06213610 | Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Unknown | Bioequivalence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06213610) |
| July 11, 2023 | NCT05940909 | Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Unknown | Bioequivalence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05940909) |
| July 7, 2023 | NCT05934799 | Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05934799) |
| January 17, 2023 | NCT05685277 | Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05685277) |
| December 8, 2022 | NCT05642845 | Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05642845) |
| June 29, 2022 | NCT05438316 | Bioequivalence Study of Two Formulations of Tablets Ramipril 10 mg in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05438316) |
| April 21, 2022 | NCT05339373 | Bioequivalence Study of Two Formulations of Tablets Aceclofenac 100 mg in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05339373) |
| September 30, 2021 | NCT05061901 | Bioequivalence Study of Two Formulations of Lisinopril Tablet 20 mg in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 38 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05061901) |
| June 10, 2021 | NCT04921566 | Bioequivalence Study of Two Formulations of Torasemide Tablet 10 mg in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04921566) |
| May 12, 2021 | NCT04882826 | Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Unknown | Bioequivalence | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04882826) |
| April 5, 2021 | NCT04830579 | Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions | Pharmtechnology LLC | Phase 1 | Unknown | Bioequivalence | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04830579) |
| February 15, 2021 | NCT04753489 | Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions | Pharmtechnology LLC | Phase 1 | Unknown | Bioequivalence | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04753489) |
| January 29, 2021 | NCT04729998 | Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions | Pharmtechnology LLC | Phase 1 | Unknown | Bioequivalence | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04729998) |
| October 25, 2019 | NCT04138888 | A Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil/ Hydrochlorothiazide After a Single Oral Dose Administration... | Pharmtechnology LLC | Phase 1 | Unknown | Bioequivalence | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04138888) |
| July 30, 2019 | NCT04038008 | Single Dose Crossover Comparative Bioavailability Study of Two Formulations of Fluconazole 200 mg in Healthy Adult Subjects Under Fasting... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04038008) |
| July 9, 2019 | NCT04012307 | The Bioequivalence Study of Two Different Formulations of Candesartan Cilexetil After a Single Oral Dose Administration Under Fasting... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04012307) |
| May 15, 2019 | NCT03951051 | The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03951051) |
| April 17, 2019 | NCT03918551 | Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03918551) |
| April 16, 2019 | NCT03915340 | Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03915340) |
| April 1, 2019 | NCT03898193 | Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck... | Pharmtechnology LLC | Phase 1 | Completed | Healthy Adults | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03898193) |
| April 1, 2019 | NCT03898011 | A Bioequivalence Study of Two Formulations Lamotrigine 100 mg Tablets and Lamictal 100 mg Tablets in Healthy Adult Volunteers Under Fasting... | Pharmtechnology LLC | Phase 1 | Completed | Healthy Adults | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03898011) |
| January 10, 2019 | NCT03799536 | Bioequivalence Study of Sotalol, Tablets, 160 mg (Pharmtechnology LLC, Belarus), and Sotalex ®, Tablets, 160 mg (Bristol-Myers Squibb GmbH... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03799536) |
| October 15, 2018 | NCT03705533 | Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03705533) |
| October 11, 2018 | NCT03702894 | Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03702894) |
| August 6, 2018 | NCT03616301 | Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder... | Pharmtechnology LLC | Phase 1 | Completed | Bioequivalence | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03616301) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 27 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 20 |
| Unknown | 7 |

## Conditions

| Condition group | Trials |
| --- | --- |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Law firms in the United States](https://specstream.ai/data/businesses/law-firms/united-states)
- [Bangladeshi restaurants in the United States](https://specstream.ai/data/businesses/bangladeshi-restaurants/united-states)
- [Otolaryngology practices in the United States](https://specstream.ai/data/businesses/otolaryngology-practices/united-states)
- [Collection agencies in the United States](https://specstream.ai/data/businesses/collection-agencies/united-states)
- [Real estate firms in the United States](https://specstream.ai/data/businesses/real-estate-firms/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
